Fusion Pharmaceuticals Inc. Long-term Investments
Fusion Pharmaceuticals Inc. had Long-term Investments of $72.58 million as of 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Long-Term Investments
us-gaap:LongTermInvestments · last filed 2024-05-07
- 2024-03-31: Long-term Investments $72.58M.
- 2023-12-31: Long-term Investments $13.73M.
- 2023-09-30: Long-term Investments $15.93M.
- 2023-06-30: Long-term Investments $28.42M.
| Period end | Long-term Investments |
|---|---|
| 2024-03-31 | $72.58M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $13.73M 10-Q · filed 2024-05-07 |
| 2023-09-30 | $15.93M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $28.42M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $11.34M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $15.76M 10-K · filed 2024-03-20 |
| 2022-03-31 | $9.90M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $19.99M 10-K · filed 2023-03-16 |
| 2021-09-30 | $45.55M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $81.97M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $51.00M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $77.08M 10-K · filed 2022-03-17 |
| 2020-09-30 | $11.10M 10-Q · filed 2020-11-10 |